Thales S.A.
Thales S.A. (0IW5.L) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Thales S.A. (0IW5.L), featuring income statements, balance sheets, and cash flow data.
Thales S.A. (0IW5.L) Income Statement & Financial Overview
Review Thales S.A. 0IW5.L income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $11.08B | $9.49B | $9.71B | $8.72B |
| Cost of Revenue | $8.22B | $6.98B | $7.22B | $6.44B |
| Gross Profit | $2.87B | $2.51B | $2.49B | $2.28B |
| Gross Profit Ratio | $0.26 | $0.26 | $0.26 | $0.26 |
| R&D Expenses | $674.40M | $599.30M | $595.30M | $512.70M |
| SG&A Expenses | $1.17B | $1.11B | $1.009B | $996.00M |
| Operating Expenses | $1.85B | $1.70B | $1.60B | $1.51B |
| Total Costs & Expenses | -$10.06B | $8.69B | $8.83B | $7.95B |
| Interest Income | $56.50M | $67.00M | $11.50M | $71.90M |
| Interest Expense | $135.60M | $153.70M | $0.00 | $49.70M |
| Depreciation & Amortization | $614.30M | $426.90M | $562.70M | $482.40M |
| EBITDA | $1.18B | $1.19B | $1.03B | $1.21B |
| EBITDA Ratio | $0.11 | $0.13 | $0.11 | $0.14 |
| Operating Income | $1.02B | $767.80M | $883.70M | $769.30M |
| Operating Income Ratio | $0.09 | $0.08 | $0.09 | $0.09 |
| Other Income/Expenses (Net) | -$594.60M | -$108.40M | -$524.90M | -$94.70M |
| Income Before Tax | $425.10M | $659.40M | $359.40M | $674.60M |
| Income Before Tax Ratio | $0.04 | $0.07 | $0.04 | $0.08 |
| Income Tax Expense | $123.20M | $124.10M | $126.80M | $125.20M |
| Net Income | $19.30M | $1.02B | $375.10M | $648.90M |
| Net Income Ratio | $0.002 | $0.11 | $0.04 | $0.07 |
| EPS | $0.09 | $4.93 | $1.80 | $3.10 |
| Diluted EPS | $0.09 | $4.93 | $1.80 | $3.09 |
| Weighted Avg Shares Outstanding | $205.31M | $206.30M | $208.30M | $209.35M |
| Weighted Avg Shares Outstanding (Diluted) | $205.31M | $206.38M | $208.50M | $209.83M |
Over the past four quarters, Thales S.A. demonstrated steady revenue growth, increasing from $8.72B in Q2 2023 to $11.08B in Q4 2024. Operating income reached $1.02B in Q4 2024, maintaining a consistent 9% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.18B, reflecting operational efficiency. Net income dropped to $19.30M, with EPS at $0.09. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan